The Future of Patient-Centric Data-Driven Healthcare

Zou, Kelly H.; Salem, Lobna A.

doi:10.1201/9781003017523-11

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clinical trials form a cornerstone, employing rigorous methodologies and diverse endpoints to comprehensively assess the product's effectiveness ( 47 ). The selection of appropriate endpoints depends on the primary mode of action; with clinical, physiological, or patient-reported outcomes being common measures ( 48 ). Post-market surveillance is essential for continuous efficacy assessment, monitoring real-world performance and potential long-term effects.…”

Section: Efficacy Assessment Of Combination Productsmentioning

confidence: 99%

Ensuring safety and efficacy in combination products: regulatory challenges and best practices

Gupta,

Tiwari,

Yadav

et al. 2024

Front. Med. Technol.

View full text Add to dashboard Cite

Combination products, amalgamating drugs, biologics, and medical devices, have revolutionized the healthcare landscape with their potential for innovative therapies. However, the intersection of diverse components within these products presents a complex regulatory environment, demanding rigorous attention to safety and efficacy. This article delves into the intricate landscape of regulatory considerations, safety, and efficacy assessments pertaining to combination products—a category at the intersection of drugs, devices, and biologics. The regulatory framework, primarily governed by the U.S. Food and Drug Administration (FDA), necessitates a nuanced classification determining the regulatory pathway. Collaboration between diverse regulatory centers, such as the Center for Drug Evaluation and Research (CDER) and the Center for Devices and Radiological Health (CDRH), underscores the integrated approach required for these innovative healthcare solutions. Safety considerations unravel the potential risks and adverse events associated with combining diverse components, emphasizing the need for robust risk assessment and mitigation strategies. The evaluation of efficacy involves sophisticated methodologies, clinical trials, and post-market surveillance, with recent advancements incorporating digital technologies. This comprehensive exploration aims to contribute to the evolving understanding and best practices in the regulatory and scientific realms, fostering collaboration and innovation in the development and assessment of combination products.

show abstract

Section: Efficacy Assessment Of Combination Productsmentioning

confidence: 99%